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Objective: To examine the efﬁcacy of a multidisciplinary non-pharmacological intervention in patients
with hand osteoarthritis (OA).
Method: Parallel group randomized controlled trial was performed in three participating rheumatology
outpatient clinics in the Netherlands. Block randomization was performed using a computer generated
permuted block scheme (blocks of four). An independent person randomly assigned 151 participants
with clinical hand OA to four sessions of multidisciplinary non-pharmacological treatment, or 30 min
education followed by 3 months waiting time. Participants and therapists were not blinded to the
assigned intervention. The research assistant who assessed all outcomes was blinded to the assigned
intervention. Subscale limitations in activities of the Australian Canadian Osteoarthritis Hand Index
(AUSCAN) and OARSI responder criteria (primary outcomes) and secondary outcome measures, were
assessed at baseline and 12 weeks. Linear or logistic regression analyses were used, where appropriate,
with the outcome as dependent and the intervention group as independent variable. The analyses were
adjusted for baseline values.
Results: At 3 months no signiﬁcant and no relevant differences were observed between the experimental
(n ¼ 76) and control group (n ¼ 75) in any of the primary or secondary outcome measures. In both groups
about one-third of patients were classiﬁed as responder.
Conclusion: There is insufﬁcient evidence to conﬁrm a clinically relevant treatment effect on the short
term, between patients who followed a multidisciplinary treatment program and those who received
only written information. Since hand OA causes a range of impairments and limitations in activities,
programs with more guidance to formulate and implement individually tailored treatment plans could
be probably more effective. Furthermore, more research is needed on the efﬁcacy of single treatment
elements.
(Dutch Trial Register trial number NTR1191).
 2013 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Background
Osteoarthritis (OA) is the most common arthritic joint disease
frequently affecting the joints of the hands1. In elderly people (>70
years) the prevalence of symptomatic hand OA is estimated to beM.J. Stukstette Clinical Health
The Netherlands.
(M.J. Stukstette).
s Research Society International. P26% for women and 13% for men2. Subjects with hand OA have dif-
ﬁculties in carrying, writing and ﬁngering small objects, resulting in
limitations in activities and restrictions in participation2,3.
The European LeagueAgainst Rheumatism (EULAR) recommends
to treat all patients with hand OAwith a combination of pharmaco-
logical and non-pharmacological treatment options4. However, no
evidence and no guidelines are available about the optimal content
andmix of non-pharmacological components. It has been suggested
to combine non-pharmacological treatment options focussing on
multiple dimensions (impairments, limitations in activities, andublished by Elsevier Ltd. All rights reserved.
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ﬁndings, indicating that perceived limitations in activities inpatients
with hand OA are closely associated with hand impairment of grip
strength and joint mobility3, and that satisfaction with the perfor-
mance of activities are associated with personal factors as self-
efﬁcacy and coping strategies3.
Research on the effectiveness of non-pharmacological treat-
ment programs in hand OA is scarce and of poor quality. Recent
reviews concluded that there is currently insufﬁcient high quality
evidence regarding the effectiveness of non-pharmacological in-
terventions for hand OA5e8, due to lack of methodological quality
of studies included in these reviews. Furthermore, interventions
scrutinized in these reviews were not multidisciplinary and did
not simultaneously focus on impairments, limitations in activities,
and personal factors such as self-efﬁcacy and coping strategies as
recommended3. Therefore, we developed a non-pharmacological
multidisciplinary and multidimensional treatment programme
for patients with hand OA. Treatment components of the pro-
gramme included self-management, daily home exercises to
enhance joint mobility and grip strength and education about
ergonomic principles9. The objective of the current study is to
determine the effectiveness of a multidisciplinary treatment
program in patients with hand OA on limitations in activities and
pain.
Methods
Design overview
One University based rheumatology outpatient centre and two
community based rheumatology outpatient centres participated in
this multicentre parallel group randomized controlled study. All
patients followed a nurse-led educational session. Then patients
were randomly assigned to the intervention group (multidisci-
plinary treatment) or a waiting time of 3 months (allocation ratio
1:1). Patients were assessed at baseline (prior to the mono-
disciplinary educational session) and at 13 weeks follow-up by a
research assistant who was blinded for treatment allocation. The
study was conducted according to good clinical practice and in
compliance with the Helsinki declaration. Each institutional
research ethics board approved the study protocol and all patients
gave signed informed consent. The trial is registered in the Dutch
Trial Register (trial number NTR1191). A copy of the trial protocol
(in Dutch) can be requested at the authors.
Setting and participants
Patients were recruited between December 2007 and January
2010. Patients who visited the outpatient clinic due to complaints
of hand OA and referral to multidisciplinary treatment was indi-
cated, were informed about the study by their rheumatologist.
If patients orally indicated to be interested in participating in the
study, the medical record of each patient was screened by the
research assistant for eligibility. Patientswere excluded on the basis
of medical records if they suffered from other rheumatic diseases,
previous joint replacement surgery in one of the hand joints, or
previous participation in a multidimensional multidisciplinary
group treatment program for hand OA. After written information
was sent to eligible patients, the researcher contacted patients
within 2 weeks by telephone to establish willingness to participate
in the study and plan a ﬁnal eligibility screening at one of the
participation centres.
Included during the ﬁnal eligibility screeningwere patients with
hand OA according to the clinical classiﬁcation criteria of the
American College of Rheumatology (ACR)10; of whom complaintsdue to OA of hands were the most or second most important
problem; who had self-reported limitations in activities due to
hand OA (measured as a score of at least 9 on the Australian Ca-
nadian Osteoarthritis Hand Index e LK3 (AUSCAN) physical func-
tioning subscale11). Excludedwere patients whowere notwilling to
participate in a group treatment program; not able to write and or
understand the Dutch language.
Interventions
Single mono-disciplinary educational session
Both study groups received the same nurse-led educational
session consisting of a 30-min explanation of written information
about OA. The written information was an adapted version of the
information leaﬂet published by the Dutch Arthritis Association for
generalized OA, and included information about the disease and
exercises to enhance mobility and grip strength.
Multidisciplinary treatment program
The multidisciplinary treatment program (experimental inter-
vention) started within a week after baseline assessments. The
program, consisted of an intake by an occupational therapist, fol-
lowed by four group based sessions (6e8 patients) of 2½e
3 h duration supervised by a specialized nurse and occupational
therapist. During an intake session an occupational therapist made
an inventory of patient speciﬁc problems in daily living, following a
semi-structured interview by means of the Canadian Occupational
Measurement Scales (COPM)12,13. After discussion with the thera-
pist, patients prioritized their own speciﬁc problems.
Elements of the multidisciplinary group treatment sessions
were: (1) self-management to enhance self-efﬁcacy to cope with
pain, fatigue, limitations in activities and participation; (2) ergo-
nomic principles (elements of joint protection); (3) daily home
exercises to improve strength and joint mobility; (4) referral for a
splint if considered necessary by an occupational therapist.
During the multidisciplinary treatment sessions discussions
among patients were encouraged to utilize patients’ expert opin-
ions. Each treatment element was repeated and built upon during
several sessions. Furthermore, each session included three to four
clearly stated take home messages; such as “use of hands and ex-
ercises will not damage your joints”. The treatment program
comprised eight exercises to enhance joint mobility of wrist and
ﬁnger joints and muscle strength of the intrinsic muscles and
extensor muscles of the ﬁngers. All exercises were practiced with
an occupational therapist during the ﬁrst treatment session. Then
patients performed the exercises daily at home for a week and
registered the number of repetitions, intensity and resistance
(colour of putty used). During the second treatment session pa-
tients set up an individual scheme with an individual built up for
each exercise together with the occupational therapist and
specialized nurse. This schemewas based on the registrations of the
performance of exercises during the ﬁrst week. Patients recorded
the progress at home daily. During the third and fourth treatment
session the progress on the exercise program was discussed and
adjusted if considered necessary. For more information about the
multidisciplinary treatment program, see Appendix 1. A detailed
description of the development and content of the multidisci-
plinary treatment program, including the exercise program is
described elsewhere9. To standardize the treatment program a slide
presentation for all treatment sessions was developed. Further-
more, manuals for both therapists and patients were developed.
Before the start of the trial all participating nurses and occupational
therapist followed an education and standardization session.
During the study, meetings were planned to perpetuate
standardization.
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Block randomization was performed using a computer gener-
ated permuted block randomization scheme using blocks of four.
Patients were randomly assigned to the experimental or control
group by an independent person, who was not responsible for
determining the eligibility of the patients, and had no information
about the persons included in the trial and no inﬂuence on the
assignment sequence. Assignments were communicated by e-mail
to the planners of the outpatient clinics. Patients were informed of
their allocation by mail.Measurements and outcomes
All primary and secondary outcome measures were obtained at
baseline and 13 weeks. Assessments were performed on a test
location by a research assistant (physical therapist).
Demographic and clinical data were collected for each patient,
including age, sex, height, weight, location of OA, time since diag-
nosis, and the presence of other chronic disorders. X-rays of the
hands were scored by a rheumatologist according to Kellgren and
Lawrence14 on a ﬁve point scale: 0: no OA, 1: doubtful OA, 2: min-
imal OA, 3: moderate OA and, 4: severe OA14. Presence of erosive OA
was deﬁned as at least one erosion at one of the hand joints.
Primary outcome measures
Primary outcome measures were the AUSCAN subscale limita-
tions in activities and the OARSI responder criteria15,16. Limitations
in activities were assessed with AUSCAN subscale limitations in
activities11,17, which contains nine items (scaled on a ﬁve-point
Likert scale) referring to limitations in activities of daily living
during the past 48 h11. The possible range of scores on the AUSCAN
physical function subscale is 0e36, with a higher score indicating
more severe problems. The AUSCAN is valid, reliable and responsive
in patients with hand OA17.
The OARSI responder criteria is a composite index that permits
presentation of results of symptom modifying clinical trials in OA
based on individual patient responses (responder yes/no). A patient
is classiﬁed as responder if there is (1) an improvement of pain
>50%; or (2) an improvement of >20% in at least two of the
following three categories: pain, physical function and patient
global assessment15,16.
Secondary outcome measures
Impairments e Pain in the last 48 h was assessed with the pain
subscale of the AUSCAN (range 0e20). Joint mobility of the elbow,
wrist, interphalangeal thumb joint, meta carpophalangeal joints,
and proximal interphalangeal joints was measured following the
Escola Paulista de Medicina (EPM)-range of motion scale18 and by
means of the Kapandji index which measures thumb opposition
(range 0e10)19. The index has been validated in RA20. A minimal
score indicates possible to do and a maximal score indicates a
normal mobility with completely accomplished movement. Grip
strength was measured with the JAMAR hand dynamometer. The
mean value (kg) of three efforts, separated by 20 s rest intervals of
each hand, was calculated.
Activities and participation e An inventory of individual prob-
lems was made in a semi-structured interview by means of the
COPM12,13.
Personal factors e Pain coping was assessed by the Pain Coping
Inventory (PCI)21,22. Beliefs in the ability to cope with adversity and
to achieve goals (self-efﬁcacy) were assessed with the Dutch
version of the General Self-Efﬁcacy Scale (GSE)23 and the Chronic
Pain Self-Efﬁcacy Scale (CPSE)24.Health-related quality of life e Quality of life was determined
with the Medical Outcomes Study Short Form 36 (SF-36). All eight
subscales were assessed25.
Self-perceived change e Patients rated their self-perceived
change on an eight-point scale (1: vastly worsened, 8: completely
recovered)26.
Adverse experiences e Participants were asked open-ended
questions about adverse experiences at each treatment session.
Blinding e A trained research assistant (physical therapist),
blinded for block size of randomization and assigned treatment,
performed the assessments. Patients were instructed not to give
information about the allocated treatment to the research assistant.
During treatment hours the research assistant was not allowed to
visit the outpatient clinic in order to further assure blinding. To
provide insight in the success of blinding the assessor was asked to
guess the assigned treatment immediately after the follow-up
assessment at week 13. Because of the type of intervention, pa-
tients and clinicians could not be blinded for the assigned treatment.
Statistical analysis
The sample size of the study was based on the ability to demon-
strate a difference of 15%27 between groups at 13 weeks, corre-
sponding with a mean difference of 0.27 units per item on the
AUSCAN subscale limitations in activities and assuming amean item
score of 1.817 at baseline. Assuming an improvement of 10% (from 1.8
to 1.6) in the control group and an improvement of 25% in the
experimental group (from 1.8 to 1.3), the target sample size was
estimated at 45 patients per group (two-tailed alpha ¼ 0.05,
beta¼ 0.80). Taking into account a drop out rate of 20% and planned
subgroup analyses 75 patients per groupwere included in this study.
An administrative assistant entered the data, which was double
checked by the researcher.
The analysis was done on an intention-to-treat basis. Linear
regression analyses and logistic regression analyses were used
where appropriate with the outcome as dependent and the inter-
vention group as independent variable and adjusted for baseline
values. Additionally (to support theunadjustedanalyseswhichwere
used for conﬁrmatory testing), we repeated the analyses adjusting
for baseline, gender, age, body mass index (BMI) and erosive OA.
Values less than 0.05 were considered statistically signiﬁcant.
The proportions of missing data on the primary outcome mea-
sures were 3% at 12 weeks. List wise deletion of missing data was
used in all analyses. All analyses were performed by using STATA
software version 10 (StataCorp, College Station, Texas).
Results
After screening of the medical history, 373 out of 539 referred
patients were invited to participate in the trial of whom 237 pa-
tients were willing and invited for a screening visit. 151 patients
were included in the trial, of whom 76 were randomized to the
intervention group and 75 to the control group (Fig.1). Themajority
of participants (n ¼ 96) were included in the Maartenskliniek Nij-
megen, 47 were included in Maartenskliniek Woerden, and eight
patients were included in the University Medical Centre Utrecht.
Most participants were female with a mean disease duration of
4 years [standard deviation (SD) ¼ 7] (Table I). There were no
relevant differences in baseline characteristics between groups.
Examples of frequently named and prioritized problems at the
baseline COPM interview were: doing and undoing buttons,
opening jars and/or bottles, carrying heavy objects and holding the
steer of a bicycle.
At 3 months follow-up there were no improvements in pain,
joint stiffness and limitations in activities within and between the
Fig. 1. Flowchart of participants.
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improvement in patient global assessment was observed within
both groups (Table II). In both groups about one-third of partici-
pants could be classiﬁed as a responder [33% versus 37% of partic-
ipants in the experimental group and the control group,
respectively: odds ratio 0.82; 95% conﬁdence interval (CI) 0.42;
1.61]. There was no change in any of the secondary outcome
measures at 3 months follow-up (Table III). Similar results for all
primary and secondary outcome measures were obtained afteradjusting for age, gender, BMI, and erosive OA (Table III). At follow-
up there was a slight increase in the use of acetaminophen in both
groups (Table IV).
Adverse events: one patient reported swollen hand and wrist
joints and increased pain after the second treatment session. After
contacting the referring rheumatologist, the patient was rediag-
nosed with psoriatic arthritis.
The research assistant guessed the assigned treatment at 13
weeks in 59.6% (Cohen’s k ¼ 0.19) of patients correctly.
Table I
Baseline characteristics of participants allocated to the intervention and control
group
Characteristic Intervention group
Intervention Control
Mean age (SD), y 60 (7) 58 (9)
Men/women, n/n (%/%) 62/14 (82/18) 63/12 (84/16)
Mean BMI (SD), kg/m2 27 (5) 27 (4)
Mean time diagnosed (SD) y 4 (6) 4 (7)
Radiological evidence OA* (n ¼ 135)
PIP OA (including IP)/no PIP OA n/n (%/%) 58/10 (85/16) 51/16 (76/24)
DIP OA/no DIP OA n/n (%/%) 65/3 (96/4) 56/11 (84/16)
CMC I OA/no CMC I OA n/n (%/%) 20/48 (70/30) 20/47 (70/30)
Erosive/non-erosive OA n/n (%/%) 39/29 (57/43) 34/33 (51/49)
Medication n (%)
NSAID 28 (37) 24 (32)
Opioids 2 (3) 3 (4)
Bisphosphonates 1 (1) 1 (1)
DMARDs 6 (8) 4 (5)
Glucosamine (chondroitine) 3 (4) 2 (3)
* X-rays of 16 patients were missing for logistic reasons or patients who declined
to make an X-ray.
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This is the ﬁrst study investigating the effectiveness of an inten-
sive group basedmultidisciplinary treatment program incorporating
self-management, ergonomic principles and exercises. Although
several guidelines recommend a multidimensional and multidisci-
plinary treatment program in hand OA, the ﬁndings of this study
suggest that such a program is not effective on the short term.Wedid
not observe any differences between the experimental and control
group in primary or secondary outcome measures. Furthermore, in
general, outcome measures remained stable between baseline and
follow-up within both groups. Based on the results of the current
study, there is insufﬁcient evidence to conﬁrm an important differ-
ence between groups. The results seem to indicate absence of evi-
dence, because the limits of the 95% CIs remain between the
predeﬁned limitsof equivalence (a15%differencebetweengroups)28.
The results of our study partially correspond with the results of
earlier research on the effect of treatment programs for handOA6,7. In
a study on the effects of a one sessionprogram incorporating exercise
and joint protection no effect on limitations in activities and painwas
found. However, in contrast with our results, positive effects were
observed on muscle strength and perceived global hand function inTable II
Summary results: primary outcome measures for each study group
Intervention group
Measurement
instrument
Experimental group (n ¼ 76) Control group (n
Total with
data
available
N (%)
Baseline
[mean (SD)]
Total with
data
available
N (%)
3 months
[mean (SD)]
Total with
data
available
N (%)
Bas
[me
AUSCAN
Painz 76 (100) 10.4 (3.4) 74 (97.4) 9.4 (2.8) 75 (100) 10.2
Functionx 76 (100) 21.0 (6.9) 74 (97.4) 18.6 (7.3) 75 (100) 21.8
Joint stiffnessk 76 (100) 2.3 (0.9) 74 (97.4) 2.2 (0.8) 75 (100) 2.4
Patient global
assessment{
76 (100) 49.5 (25.1) 75 (98.7) 60.4 (20.6) 75 (100) 51.3
* Adjusted for baseline.
y Adjusted for baseline, gender, age, BMI and erosive OA.
z Possible scoring range 0e20, lower scores depict more favourable outcomes.
x Possible scoring range 0e36, lower scores depict more favourable outcomes.
jj Possible scoring range 0e4, lower scores depict more favourable outcomes.
{ Possible scoring range 0e100, higher scores depict more favourable outcomes.favour of the experimental group29. A possible explanation for the
difference in effects between studies on muscle strength could be
differences in the type and intensity of exercises. In the study of
Stamm et al. patients were encouraged to do range of motion exer-
cises 10 times daily whereas in our study patients were advised to do
both strength and range of motion exercises once or twice daily. In
another study investigating the additional effect of the supply of
splints and technical aids to education on exercises and joint pro-
tection a positive effect on the primary outcome measure (activity
performance and satisfaction with performance as measured with
the COPM), was found, whereas no effects were observed in other
outcomemeasures30. This contrast in ﬁndingsmight be explained by
the fact that in the latter study technical aids were supplied by the
careprovideraspartof the interventionwhereaspatients inour study
were encouraged to acquire advised aids themselves.
Our results indicate that a multidimensional self-management
programme in a group setting might not be suitable in patients
with hand OA. As OA of the hands may cause various impairments
and limitations in activities, individual treatment goals could vary
considerably among patients. An important feature of our group
based multidimensional self-management intervention was that it
addressed all possible problems related to hand OA in a non-
directive approach. Patients were encouraged to develop and to
decide their own treatment plan to achieve individually set treat-
ment goals. The intervention evaluated in the current study existed
of numerous treatment elements. Pros and cons of certain treat-
ment options were extensively discussed among group members
and therapists. As a result participants may have received toomuch
information on all possible treatment options and were not capable
to pick up relevant information for themselves. It is conceivable
that this non-directive approach offered insufﬁcient guidance to
formulate and implement individually tailored treatment plans.
Furthermore, patients may have perceived certain treatment ele-
ments such as exercises to improve strength versus elements of
joint protection to reduce pressure on joints as confusing and
contradictory. We believe that it is possible that the single treat-
ment elements of our programme are effective, but that interaction
of treatment elements counteracts the positive effects of the single
elements. Therefore, in our view and in line with other authors
reporting on results of non-pharmacological intervention
studies8,29,31 we advocate that further research should focus on the
effectiveness of single treatment elements, targeting on individual
patient characteristics and needs.¼ 75) Difference*
(95% CI) at
3 months
Differencey
(95% CI) at
3 months
eline
an (SD)]
Total with
data
available
N (%)
3 months
[mean (SD)]
Exp-contr Exp-contr
(3.3) 72 (96) 9.0 (3.7) 0.40 (0.50; 1.29) 0.65 (0.38; 1.67)
(6.3) 72 (96) 18.8 (6.4) 0.49 (1.01; 2.00) 0.96 (0.74; 2.65)
(0.8) 72 (96) 2.1 (0.9) 0.14 (0.09; 0.37) 0.10 (0.16; 0.35)
(24.8) 72 (96) 66.0 (20.6) 5.21 (11.43; 1.01) 6.75 (13.76; 0.25)
Table III
Summary results: secondary outcome measures for each study group
Intervention group
Measurement
instrument
Experimental group (n ¼ 76) Control group (n ¼ 75) Difference*
(95% CI) at
3 months
Differencey
(95% CI) at
3 months
Total with
data
available
N (%)
Baseline
[mean (SD)]
Total with
data
available
N (%)
3 months
[mean (SD)]
Total with
data
available
N (%)
Baseline
[mean (SD)]
Total with
data
available
N (%)
3 months
[mean (SD)]
Exp-contr Exp-contr
COPM
Activityz 72 (94.7) 5.3 (1.6) 75 (98.7) 5.2 (1.3) 70 (93.3) 5.5 (0.15) 72 (96) 5.5 (0.16) 0.15 (0.54; 0.23) 0.14 (0.57; 0.29)
Participationz 72 (94.7) 4.7 (1.5) 75 (98.7) 5.3 (1.5) 70 (93.3) 4.9 (1.4) 72 (96) 5.2 (1.5) 0.14 (0.30; 0.59) 0.03 (0.47; 0.52)
Pain coping (PCI)
Transformationx 74 (97.4) 2.4 (0.6) 74 (97.4) 2.3 (0.6) 71 (94.7) 2.4 (0.6) 72 (96) 2.3 (0.7) 0.07 (0.09; 0,24) 0.06 (0.13; 0.24)
Distractingx 75 (98.7) 2.5 (0.7) 74 (97.4) 2.5 (0.6) 71 (94.7) 2.5 (0.6) 72 (96) 2.5 (0.6) 0.01 (0.17; 0.14) 0.07 (0.24; 0.10)
Demandsx 73 (96.1) 2.2 (0.6) 74 (97.4) 2.3 (0.6) 71 (94.7) 2.2 (0.6) 72 (96) 2.3 (0.5) 0.01 (0.16; 0.18) 0.02 (0.18; 0.21)
Retreatingx 74 (97.4) 1.6 (0.4) 74 (97.4) 1.6 (0.4) 71 (94.7) 1.7 (0.5) 72 (96) 1.6 (0.4) 0.10 (0.00; 0.19) 0.09 (0.02; 0.19)
Worryingx 75 (98.7) 1.7 (0.3) 74 (97.4) 1.7 (0.4) 71 (94.7) 1.7 (0.3) 72 (96) 1.7 (0.4) 0.01 (0.1; 0.12) 0.04 (0.08; 0.16)
Restingx 75 (98.7) 2.0 (0.5) 74 (97.4) 2.0 (0.4) 71 (94.7) 2.0 (0.5) 72 (96) 2.0 (0.5) 0.00 (0.11; 0.11) 0.02 (0.14; 0.10)
Arthritis self-efﬁcacy
Paink 75 (98.7) 60.1 (13.7) 74 (97.4) 59.3 (12.9) 71 (94.7) 64.0 (13.1) 72 (96) 61.1 (13.7) 0.61 (3.00; 4.22) 0.36 (4.45; 3.73)
Physical functionk 75 (98.7) 73.5 (16.8) 74 (97.4) 70.4 (16.2) 71 (94.7) 73.5 (15.2) 72 (96) 72.9 (15.8) 2.91 (6.18; 0.36) 3.46 (7.07; 0.15)
Other symptomsk 75 (98.7) 66.0 (15.0) 74 (97.4) 65.5 (14.4) 71 (94.7) 68.6 (14.7) 72 (96) 67.7 (13.8) 0.64 (4.31; 3.04) 0.10 (3.87; 4.06)
Dutch GSEyy 73 (96.1) 33.1 (4.6) 73 (96.1) 32.1 (4.8) 71 (94.7) 32.5 (4.5) 72 (96) 32.6 (4.2) 0.47 (1.39; 0.45) 0.45 (1.45; 0.56)
SF-36
Physical function{ 75 (98.7) 41.7 (8.8) 74 (97.4) 41.1 (9.4) 69 (92) 42.5 (6.8) 72 (96) 42.3 (7.6) 0.14 (1.90; 1.62) 0.04 (2.01; 2.09)
Role professional{ 75 (98.7) 36.7 (8.0) 74 (97.4) 37.6 (6.8) 70 (93.3) 36.7 (7.8) 72 (96) 38.7 (7.6) 1.23 (2.95; 0.49) 1.28 (3.12; 0.56)
Bodily pain{ 75 (98.7) 40.9 (6.9) 74 (97.4) 41.0 (6.3) 71 (94.7) 41.3 (8.0) 72 (96) 41.9 (7.5) 0.08 (1.71; 1.88) 0.03 (1.93; 1.87)
General health{ 74 (97.4) 45.2 (7.8) 74 (97.4) 45.9 (8.1) 71 (94.7) 45.8 (8.3) 72 (96) 45.4 (7.8) 1.10 (1.01; 3.21) 0.46 (1.91; 2.84)
Vitality{ 75 (98.7) 49.3 (7.0) 74 (97.4) 49.2 (7.9) 71 (94.7) 50.0 (8.5) 72 (96) 50.1 (8.1) 0.12 (2.09; 1.85) 0.22 (2.35; 1.90)
Social function{ 75 (98.7) 46.3 (9.8) 74 (97.4) 47.9 (10.2) 71 (94.7) 46.6 (8.8) 72 (96) 48.3 (8.6) 0.16 (2.25; 2.58) 0.29 (2.31; 2.91)
Role emotional{ 75 (98.7) 42.7 (11.9) 74 (97.4) 42.9 (11.3) 70 (93.3) 44.7 (10.1) 72 (96) 44.8 (11.0) 0.17 (3.28; 2.93) 0.40 (3.80; 2.10
Mental health{ 74 (97.4) 48.9 (7.4) 74 (97.4) 49.4 (8.3) 71 (94.7) 49.3 (8.6) 72 (96) 50.6 (8.4) 0.43 (2.46; 1.60) 0.23 (2.45; 1.99)
Physical
component score{
74 (97.4) 39.5 (7.3) 74 (97.4) 39.8 (6.7) 68 (90.7) 39.4 (6.9) 72 (96) 39.9 (6.7) 0.14 (1.62; 1.35) 0.17 (1.81; 1.47)
Mental
component score{
74 (97.4) 49.7 (9.0) 74 (97.4) 50.3 (9.4) 68 (90.7) 50.7 (10.0) 72 (96) 51.6 (9.8) 0.27 (2.13; 2.67) 0.09 (2.74; 2.57)
Muscle strength
Grip 76 (100) 19.9 (9.3) 74 (97.4) 20.9 (9.2) 75 (100) 21.8 (8.9) 72 (96) 23.1 (9.9) 0.31 (1.85; 1.22) 0.54 (2.09; 1.00)
Pinch 76 (100) 2.8 (1.3) 74 (97.4) 2.9 (1.4) 75 (100) 3.0 (1.4) 72 (96) 3.1 (1.3) 0.10 (0.13; 0.32) 0.06 (0.30; 0.19)
Lateral grip 75 (98.7) 5.4 (2.5) 74 (97.4) 5.4 (2.4) 75 (100) 5.7 (2.2) 72 (96) 5.7 (2.2) 0.02 (0.33; 0.29) 0.07 (0.41; 0.27)
Joint mobility
EPM ROM# 72 (94.7) 3.4 (2.3) 75 (98.7) 3.3 (1.96) 71 (94.7) 3.4 (2.2) 71 (94.7) 3.2 (2.0) 0.26 (0.26; 0.77) 0.11 (0.44; 0.65)
Kapandji thumb** 75 (98.7) 8.7 (1.8) 75 (98.7) 9.05 (1.04) 74 (98.7) 8.7 (2.1) 72 (96) 9.0 (1.0) 0.20 (0.17; 0.56) 0.12 (0.31; 0.54)
* Adjusted for baseline.
y Adjusted for baseline, gender, age, BMI and erosive OA.
z Possible scoring range 1e10, higher scores depict more favourable outcomes.
x Possible scoring range 0e4, higher scores mean more frequent use of this coping style when patients are in pain.
k Possible scoring range 1e100, higher scores depict more favourable outcomes.
{ Norm ¼ 50, higher scores depict more favourable outcomes.
# Possible scoring range 0e27, lower scores depict more favourable outcomes.
** Possible scoring range 0e10, higher scores depict more favourable outcomes.
yy Possible scoring range 10e40, higher scores depict higher level of self efﬁcacy.
Table IV
Medication use for each study group
Medication Intervention group
Experimental Control
Baseline
[number (%)]
3 months
[number (%)]
Baseline
[number (%)]
3 months
[number (%)]
Acetaminophen 28 (37) 34 (45) 24 (32) 31 (43)
NSAID 28 (37) 31 (41) 24 (32) 22 (31)
Opioids 2 (3) 2 (3) 3 (4) 4 (6)
Bisphosphonates 1 (1) 2 (3) 1 (1) 0 (0)
DMARDs 6 (8) 5 (7) 4 (5) 2 (3)
Glucosamine
(chondroitine)
3 (4) 2 (3) 2 (3) 4 (5)
M.J. Stukstette et al. / Osteoarthritis and Cartilage 21 (2013) 901e910906There are a few limitations to this study that need to be
mentioned. First of all, given the number of patients excluded
due to other rheumatic diseases or not meeting the ACR classi-
ﬁcation criteria for hand OA, the patients included in our study
only partially represent patients with hand OA in clinical prac-
tice. It is likely that patients who fulﬁl the ACR classiﬁcation
criteria have more severe OA than patients who did not meet
these criteria. It is possible that patients in an earlier stage of OA
would have beneﬁted from the multidimensional treatment
program investigated in this study. Secondly, in the current study
no long-term effectiveness was investigated. The Medical Ethics
Review Board advised us not to withhold our patients in the
control group the experimental intervention for more than 3
months. So, the control group started treatment immediately
after 3 months follow-up. The multidimensional treatment
M.J. Stukstette et al. / Osteoarthritis and Cartilage 21 (2013) 901e910 907program investigated in this study incorporated several ele-
ments directed at behavioural change. Behavioural change oc-
curs gradually and takes time32. It is conceivable that a 3 months
follow-up is too short to determine positive effects of a treat-
ment program that incorporates elements directed at behav-
ioural change. This study is part of a larger study in which also
another research question, namely the added value of a booster
session 6 months after completion of the treatment program in
both groups will be evaluated. For these reasons, our design does
not allow between group comparisons on the long-term effec-
tiveness of our treatment program (Dutch Trial Register trial
number NTR1191). Thirdly, there is no consensus about outcome
measures or response criteria in trials investigating the effec-
tiveness of non-pharmacological treatment in patients with hand
OA33. Therefore in the current study both the OARSI response
criteria and the AUSCAN subscale limitations in activities were
used as primary outcome measures. A frequently mentioned
problem when using more than one primary outcome measure,
is an inﬂated chance for false positive conclusions (multiplicity).
Despite sufﬁcient power, no difference on any of the outcome
measures was found between treatment groups. We therefore
decided, not to adjust for type I error (false positive outcome),
simply because the risk for a type I error was no issue when
interpreting the results of our trial. Furthermore a great disad-
vantage in the adjustment of a type I error is the increasing risk
for a type II error. International consensus about the outcome
measures that should be used in non-pharmacological trials in
patients with hand OA is necessary to avoid multiplicity issues in
future research. Fourthly, we did not measure adherence to the
different treatment elements. Research has shown that treat-
ment effects on the short and long term depend on adherence to
the recommended treatment34. In the current study it was
decided not to measure adherence to the different treatment
elements to ensure blinding to the assigned group (experimental
or control) of the research assistant who was responsible for the
data collection. Finally, it is possible that treatment effects were
beyond the scope of the primary and secondary outcome mea-
sures of our study. Our choice of primary outcome measures, i.e.,Appendix 1
Multidisciplinary treatment program*
Session
(duration
in h)
Clinicians Treatment components C
d
Intake
(1)
Occupational
therapist
 Screening
 Formulating individual
treatment goals


1
(2,5)
Occupational
therapist
& specialized
nurse
 Self-management to
enhance self-efﬁcacy to
cope with pain, limitations
in activities and participation
 Ergonomic principles
 Daily home exercises to
improve strength and
hand mobility




pain and limitations in activities reﬂected the most dominant
problems in patients with hand OA1. Important aspects
addressed in our program as adherence to daily exercise regi-
mens, the application of ergonomic principles and the usage of
adaptive devices in daily life are not fully captured in our pri-
mary and secondary measures. However, given the consistency
of our ﬁndings we believe that it is unlikely that our intervention
had an impact on factors believed to mediate effects on self-ef-
ﬁcacy, pain and limitations in activities.
In this randomized controlled trial there is insufﬁcient evidence
to conﬁrm an important or clinically relevant treatment effect on
the short term, between patients who followed a multidisciplinary
treatment program and those who received only written informa-
tion. Since hand OA causes a range of impairments and limitations
in activities, programs with more guidance to formulate and
implement individually tailored treatment plans could be probably
more effective. Furthermore, more research is needed on the efﬁ-
cacy of single treatment elements.
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Association.ontent of the session (and
uration in min)
Take home messages
Screenings questionnaire
(10 min)
Semi-structured interview
(COPM) (50 min)
e
Discussion about common
problems due to hand OA
and information about the
disease (30 min)
Information about treatment
options (medication (20 min),
splints (5 min), exercises (5 min)
Ergonomic principles (20 min)
Practicing exercises to increase
grip strength and joint mobility
(20 min)
Instruction to ﬁll in an activity
diary (10 min)
 OA: it is not to cure, but
there is something to do
to deal with it
 Know which medication
you swallow and how and
when to swallow it
 Ergonomic principles can
help you act easier in
daily life
 Be smart and act easier
 Normal load does not lead
to additional joint damage
 Exercise and normal use
of hands do not lead to
additional joint damage
 Maintaining/improving
muscle strength helps you to
continue to perform activities
(continued on next page)
Appendix 1 (continued )
Session
(duration
in h)
Clinicians Treatment components Content of the session (and
duration in min)
Take home messages
2
(3)
Occupational
therapist
& specialized
nurse
 Self-management to enhance
self-efﬁcacy to cope with pain,
fatigue, limitations in activities
and participation
 Ergonomic principles
 Daily home exercises to
improve strength and hand
mobility
 Discussion about the relation
of daily activities versus pain,
fatigue, joy and limitations in
activities by means of discussing
activity diaries (30 min)
 Education and discussion about
strategies to cope with pain, fatigue
and limitations in activities (balance
between rest and physical activity,
individual use of medication, use
of compensatory strategies in daily
activities, use of aids, use of splints)
(70 min)
 Demonstration of aids and practicing
with aids and ergonomics (35 min)
 Practicing exercises to increase grip
strength and joint mobility (15 min)
 Formulating an individual action
plan to achieve individual treatment
goals (20 min)
 Pain is not always a reason
to worry
 Know your limit and dare
to set your limit
 Communicate with people
in your environment
 You are experienced with
your disease, ﬁnd out what
helps you
 Normal load does not lead
to additional joint damage
 Exercises help you to reduce
joint stiffness
3
(2,5)
Occupational
therapist
& specialized
nurse
 Self-management to enhance
self-efﬁcacy to cope with pain,
fatigue, limitations in activities
and participation
 Referral for splints if considered
necessary
 Daily home exercises to improve
strength and hand mobility
 Ergonomic principles
 Discussion on the progress of the
action plan to achieve individual
treatment goals (25 min)
 Discussion and reﬂection on
strategies to cope with pain, fatigue
and limitations in activities (balance
between rest and physical activity,
individual use of medication, use
of compensatory strategies in daily
activities, use of aids) (20 min)
 Education and discussion about
splints (referral for splints if
necessary) (25 min)
 Practicing exercises to increase
grip strength and joint mobility
(15 min)
 Practicing with aids and
ergonomics in a kitchen (60 min)
Repetition of the aforementioned
take home messages
4
(2,5)
Occupational
therapist
& specialized
nurse
 Self-management to enhance
self-efﬁcacy to cope with pain,
fatigue, limitations in activities
and participation
 Daily home exercises to improve
strength and hand mobility
 Discussion about the relation
of daily activities versus pain,
fatigue, joy and limitations
in activities by means of
discussing diaries (30 min)
 Discussion and reﬂection on
strategies to cope with pain,
fatigue and limitations in
activities (balance between
rest and physical activity,
individual use of medication,
use of compensatory strategies
in daily activities, use of aids,
use of splints) (20 min)
 Discussion on the progress of
individual treatment goals
(25 min)
 Discussion about problems
experienced in daily life and
possible solutions by means
of diaries (25 min)
 Practicing exercises to increase
grip strength and joint mobility
(15 min)
 Evaluation if patients’ personal
goals were established and
evaluation of the treatment
program (25 min)
Repetition of the aforementioned
take home messages
* Stukstette M, Hoogeboom T, de Ruiter R, Koelmans P, Veerman E, den Broeder A, et al. A multidisciplinary and multidimensional intervention for patients with hand
osteoarthritis. Clin Rehabil 2012;26:99e110. http://dx.doi.org/10.1177/0269215511417739.
M.J. Stukstette et al. / Osteoarthritis and Cartilage 21 (2013) 901e910908
M.J. Stukstette et al. / Osteoarthritis and Cartilage 21 (2013) 901e910 909Supplementary material
Supplementary data associated with this article can be found in
the online version, at http://dx.doi.org/10.1016/j.joca.2013.03.016.
References
1. Bijlsma JW, Berenbaum F, Lafeber FP. Osteoarthritis: an update
with relevance for clinical practice. Lancet 2011;377:2115e26,
http://dx.doi.org/10.1016/S0140-6736(11)60243-2.
2. Zhang Y, Niu J, Kelly-Hayes M, Chaisson CE, Aliabadi P,
Felson DT. Prevalence of symptomatic hand osteoarthritis and
its impact on functional status among the elderly: The Fra-
mingham Study. Am J Epidemiol 2002;156:1021e7.
3. Kjeken I, Dagﬁnrud H, Slatkowsky-Christensen B, Mowinckel P,
Uhlig T, Kvien TK, et al. Activity limitations and participation
restrictions in women with hand osteoarthritis: patients’ de-
scriptions and associations between dimensions of functioning.
Ann Rheum Dis 2005;64:1633e8.
4. Zhang W, Doherty M, Leeb BF, Alekseeva L, Arden NK,
Bijlsma JW, et al. EULAR evidence-based recommendations for
the diagnosis of hand osteoarthritis: report of a task force of
ESCISIT. Ann Rheum Dis 2009;68:8e17, http://dx.doi.org/
10.1136/ard.2007.084772.
5. Kjeken I, Smedslund G, Moe RH, Slatkowsky-Christensen B,
Uhlig T, Hagen KB. Systematic review of design and effects of
splints and exercise programs in hand osteoarthritis. Arthritis
Care Res (Hoboken) 2011;63:834e48, http://dx.doi.org/10.1002/
acr.20427.
6. Moe RH, Kjeken I, Uhlig T, Hagen KB. There is inadequate ev-
idence to determine the effectiveness of nonpharmacological
and nonsurgical interventions for hand osteoarthritis: an
overview of high-quality systematic reviews. Phys Ther
2009;89:1363e70.
7. Mahendira D, Towheed TE. Systematic review of non-surgical
therapies for osteoarthritis of the hand: an update. Osteoar-
thritis Cartilage 2009;17:1263e8.
8. Ye L, Kalichman L, Spittle A, Dobson F, Bennell K. Effects of
rehabilitative interventions on pain, function and physical
impairments in people with hand osteoarthritis: a systematic
review. Arthritis Res Ther 2011;13, http://dx.doi.org/10.1186/
ar3254. R28.
9. Stukstette M, Hoogeboom T, de Ruiter R, Koelmans P,
Veerman E, den Broeder A, et al. A multidisciplinary and
multidimensional intervention for patients with hand osteo-
arthritis. Clin Rehabil 2012;26:99e110, http://dx.doi.org/
10.1177/0269215511417739.
10. Altman R, Alarcon G, Appelrouth D, Bloch D, Borenstein D,
Brandt K, et al. The American College of Rheumatology criteria
for the classiﬁcation and reporting of osteoarthritis of the
hand. Arthritis Rheum 1990;33:1601e10.
11. Bellamy N, Campbell J, Haraoui B, Buchbinder R, Hobby K,
Roth JH, et al. Dimensionality and clinical importance of pain
and disability in hand osteoarthritis: development of the
Australian/Canadian (AUSCAN) Osteoarthritis Hand Index.
Osteoarthritis Cartilage 2002;10:855e62.
12. McColl MA, Paterson M, Davies D, Doubt L, Law M. Validity and
community utility of the Canadian Occupational Performance
Measure. Can J Occup Ther 2000;67:22e30.
13. Law M, Baptiste S, McColl M, Opzoomer A, Polatajko H,
Pollock N. The Canadian occupational performance measure:
an outcome measure for occupational therapy. Can J Occup
Ther 1990;57:82e7.
14. Kellgren JH, Lawrence JS. Radiological assessment of osteo-
arthrosis. Ann Rheum Dis 1957;16:494e502.15. Pham T, van der HD, Altman RD, Anderson JJ, Bellamy N,
Hochberg M, et al. OMERACT-OARSI initiative: Osteoarthritis
Research Society International set of responder criteria for
osteoarthritis clinical trials revisited. Osteoarthritis Cartilage
2004;12:389e99.
16. Pham T, van der HD, Lassere M, Altman RD, Anderson JJ,
BellamyN,etal.Outcomevariables forosteoarthritisclinical trials:
the OMERACT-OARSI set of responder criteria. J Rheumatol
2003;30:1648e54.
17. Bellamy N, Campbell J, Haraoui B, Gerecz-Simon E,
Buchbinder R, Hobby K, et al. Clinimetric properties of the
AUSCAN Osteoarthritis Hand Index: an evaluation of reli-
ability, validity and responsiveness. Osteoarthritis Cartilage
2002;10:863e9.
18. Vliet Vlieland TP, van den Ende CH, Breedveld FC, Hazes JM.
Evaluation of joint mobility in rheumatoid arthritis trials: the
value of the EPM-range of motion scale. J Rheumatol 1993;20:
2010e4.
19. Kapandji A. Clinical test of apposition and counter-apposition
of the thumb. Ann Chir Main 1986;5:67e73.
20. Lefevre-Colau MM, Poiraudeau S, Oberlin C, Demaille S,
Fermanian J, Rannou F, et al. Reliability, validity, and respon-
siveness of the modiﬁed Kapandji index for assessment of
functional mobility of the rheumatoid hand. Arch Phys Med
Rehabil 2003;84:1032e8.
21. Kraaimaat FW, Evers AW. Pain-coping strategies in chronic
pain patients: psychometric characteristics of the pain-coping
inventory (PCI). Int J Behav Med 2003;10:343e63.
22. Perrot S, Poiraudeau S, Kabir M, Bertin P, Sichere P, Serrie A,
et al. Active or passive pain coping strategies in hip and knee
osteoarthritis? Results of a national survey of 4,719 patients in
a primary care setting. Arthritis Rheum 2008;59:1555e62,
http://dx.doi.org/10.1002/art.24205.
23. Luszczynska A, Scholz U, Schwarzer R. The general self-efﬁcacy
scale: multicultural validation studies. J Psychol 2005;139:
439e57.
24. Anderson KO, Dowds BN, Pelletz RE, Edwards WT, Peeters-
Asdourian C. Development and initial validation of a scale to
measure self-efﬁcacy beliefs in patients with chronic pain. Pain
1995;63:77e84.
25. Ware Jr JE, Sherbourne CD. The MOS 36-item short-form
health survey (SF-36). I. Conceptual framework and item se-
lection. Med Care 1992;30:473e83.
26. Van der Heijden GJ. Shoulder Disorder Treatment: Efﬁcacy of
Ultrasound and Electrotherapy 1996.
27. Anonymous. Philadelphia panel evidence-based clinical prac-
tice guidelines on selected rehabilitation interventions: over-
view and methodology. Phys Ther 2001;81:1629e40.
28. Alderson P. Absence of evidence is not evidence of absence. BMJ
2004;328:476e7, http://dx.doi.org/10.1136/bmj.328.7438.476.
29. Stamm TA, Machold KP, Smolen JS, Fischer S, Redlich K,
Graninger W, et al. Joint protection and home hand exercises
improve hand function in patients with hand osteoarthritis: a
randomized controlled trial. Arthritis Rheum 2002;47:44e9.
30. Kjeken I, Darre S, Smedslund G, Hagen KB, Nossum R. Effect of
assistive technology in hand osteoarthritis: a randomised
controlled trial. Ann Rheum Dis 2011;70:1447e52, http://
dx.doi.org/10.1136/ard.2010.148668.
31. Rogers MW, Wilder FV. Exercise and hand osteoarthritis symp-
tomatology: a controlled crossover trial. J HandTher 2009;22:10e
7, http://dx.doi.org/10.1016/j.jht.2008.09.002. discussion 19e20;
quiz 18.
32. Prochaska JO, DiClemente CC, Norcross JC. In search of how
people change. Applications to addictive behaviors. Am Psy-
chol 1992;47:1102e14.
M.J. Stukstette et al. / Osteoarthritis and Cartilage 21 (2013) 901e91091033. Maheu E, Altman RD, Bloch DA, Doherty M, Hochberg M,
Mannoni A, et al. Design and conduct of clinical trials in pa-
tients with osteoarthritis of the hand: recommendations from
a task force of the Osteoarthritis Research Society Interna-
tional. Osteoarthritis Cartilage 2006;14:303e22.34. Pisters MF, Veenhof C, Schellevis FG, Twisk JW, Dekker J, De
Bakker DH. Exercise adherence improving long-term patient
outcome in patients with osteoarthritis of the hip and/or knee.
ArthritisCareRes (Hoboken)2010;62:1087e94,http://dx.doi.org/
10.1002/acr.20182.
